231 related articles for article (PubMed ID: 28805609)
21. [Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
Pavón-Paz I; Rosado-Sierra JA; Balsa-Bretón MÁ; Guijarro-Armas G; Merino-Viveros M; Penín-Gonzalez FJ
Med Clin (Barc); 2016 Feb; 146(3):104-7. PubMed ID: 26343158
[TBL] [Abstract][Full Text] [Related]
22. F-18 FDG PET in detecting uterine leiomyoma.
Lin CY; Ding HJ; Chen YK; Liu CS; Lin CC; Kao CH
Clin Imaging; 2008; 32(1):38-41. PubMed ID: 18164393
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
Inubashiri E; Hata K; Kanenishi K; Shiota A; Ohno M; Yamamoto Y; Nishiyama Y; Ohkawa M; Hata T
J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544
[TBL] [Abstract][Full Text] [Related]
24. Journal Club: Diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer.
Miyake KK; Nakamoto Y; Kanao S; Tanaka S; Sugie T; Mikami Y; Toi M; Togashi K
AJR Am J Roentgenol; 2014 Aug; 203(2):272-9. PubMed ID: 25055259
[TBL] [Abstract][Full Text] [Related]
25. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
26. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
29. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism.
Lee EJ; Moon SH; Choi JY; Lee KS; Choi YS; Choe YS; Lee KH; Kim BT
ANZ J Surg; 2013 May; 83(5):342-7. PubMed ID: 22943630
[TBL] [Abstract][Full Text] [Related]
31. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
Yamane T; Takaoka A; Kita M; Imai Y; Senda M
Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
[TBL] [Abstract][Full Text] [Related]
32. Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings.
Gong J; Dong A; Wang Y; Zhang X; Yang P; Wang L; Jing W
Medicine (Baltimore); 2016 Apr; 95(17):e3532. PubMed ID: 27124063
[TBL] [Abstract][Full Text] [Related]
33. F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.
Takahashi Y; Takashima S; Watanabe S; Tomita Y; Hakucho T; Miyake C; Morimoto D; Hosoki T; Nakanishi K; Higashiyama M
Acta Radiol; 2013 Mar; 54(2):164-8. PubMed ID: 23138022
[TBL] [Abstract][Full Text] [Related]
34. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
35. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
Kunawudhi A; Wong AK; Alkasab TK; Mahmood U
Asian Pac J Cancer Prev; 2016; 17(8):4143-7. PubMed ID: 27644675
[TBL] [Abstract][Full Text] [Related]
37. Added value of [
Follenfant E; Balamoutoff N; Lawson-Ayayi S; Dutronc H; Dupon M; Vital JM; Delobel P; Durox H; de Clermont-Gallerande H; Fernandez P; Dauchy FA
Joint Bone Spine; 2019 Jul; 86(4):503-508. PubMed ID: 30711697
[TBL] [Abstract][Full Text] [Related]
38. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
39. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
[TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Karan B; Pourbagher A; Torun N
J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
